Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Corrigendum
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,084 | Dovepress* | 4,052+ | 250 | 4,302 | |
| PubMed Central* | 32 | 21 | 53 | ||
| Totals | 4,084 | 271 | 4,355 | ||
| *Since 13 May 2022 | |||||
View citations on PubMed Central and Google Scholar